Agilent Technologies, Inc.

A Q4 2025

Reported: 2025-11-25

Agilent Technologies delivered a robust fourth quarter in fiscal 2025, with revenue rising 7.2% year-over-year to $1.86 billion, marking the sixth consecutive quarter of core growth acceleration and exceeding guidance.

Key takeaways

Earnings per share reached $1.59, surpassing the midpoint of guidance.
Strong demand in liquid chromatography (LC) and liquid chromatography-mass spectrometry (LCMS) contributed to broad-based momentum across the portfolio.
The Ignite operating system drove over 200 basis points of sequential margin improvement.
Innovative product launches, such as the Infinity 3 and Pro IQ LCMS, yielded significant customer engagement and sales growth.
Agilent's focus on artificial intelligence is enhancing operational efficiency and accelerating innovation across its product lines.

View recap

Abercrombie & Fitch Co.

ANF Q3 2025

Reported: 2025-11-25

Abercrombie & Fitch reported a strong third quarter with record sales of $1.3 billion, marking the twelfth consecutive quarter of growth, driven by significant performance across brands and strategic investments.

Key takeaways

Net sales increased 7% year-over-year, with earnings per share exceeding expectations at $2.36.
Hollister brand demonstrated exceptional growth with a 16% increase in net sales, supported by strong marketing initiatives and inventory management.
Share repurchases of $100 million completed in the quarter total $350 million year-to-date, representing 9% of shares outstanding.
Gross margin reached 62.5% despite a 210 basis point adverse tariff impact, reflecting effective cost management.
The company is optimistically narrowing full-year sales outlook towards the higher end of previous guidance as it approaches the holiday season.

View recap

Atour Lifestyle Holdings Limited American Depositary Shares

ATAT Q3 2025

Reported: 2025-11-25

Atour Lifestyle Holdings reported a strong third quarter in 2025, with RevPAR nearly recovering to pre-pandemic levels and record hotel openings demonstrating robust market demand and strategic growth initiatives.

Key takeaways

RevPAR reached RMB 371.3, recovering to 97.8% of Q3 2024 levels, while occupancy and average daily rates were nearly at par with prior year figures.
Opened 152 new hotels in Q3, marking a record quarter and expanding total operations to 1,948 hotels, a 27.1% year-over-year increase.
Saka Hotel's RevPAR exceeded RMB 900, demonstrating strong performance in the upper-scale lifestyle segment with positive market feedback on new properties.
Atour's innovative product offerings, particularly in the ATURE series, are resonating well with consumers, evidenced by solid revenue per available room growth.
The pipeline remains strong with 754 hotels under development, aligning with the strategic target of 2,000 premier hotels by year-end.

View recap

Blue Bird Corporation

BLBD Q4 2025

Reported: 2025-11-25

Blue Bird reported a record fiscal 2025 with $1.48 billion in revenue and $221 million in adjusted EBITDA, despite ongoing tariff challenges and a reduction in backlog.

Key takeaways

Achieved record sales of 9,409 buses, $133 million higher than last year, with 901 electric vehicles sold, accounting for 9.6% of total sales.
Adjusted EBITDA increased by $38 million year-over-year, representing 15% of total revenue.
Backlog decreased to 3,100 units, but has since improved to nearly 4,000 units, including 850 EVs, indicating strong future demand.
Continued investment in manufacturing automation and expansion strategies aimed at enhancing cost efficiencies and competitiveness.
Pricing discipline remains strong with year-over-year bus price increases, maintaining margin neutrality amid tariff recovery efforts.

View recap

BioLineRx Ltd.

BLRX Q3 2025

Reported: 2025-11-25

BioLineRx reported a transformative quarter driven by the establishment of a joint venture with Hemispherian to develop GLIX1, a promising treatment for glioblastoma, while maintaining a robust pipeline with significant potential in multiple cancer indications.

Key takeaways

Established a joint venture with Hemispherian to develop GLIX1 for glioblastoma, enhancing clinical and regulatory capabilities.
GLIX1 has a unique mechanism targeting DNA damage response, with potential applications in various cancer types, supported by impressive preclinical results.
Company anticipates initiating a Phase I/IIa clinical trial for GLIX1 in early 2026, with data expected in 2027.
A recently granted patent broadens GLIX1’s protection until at least 2040, strengthening its market position against competitors.
The addressable market for GLIX1 targeting glioblastoma alone exceeds $3.7 billion in the U.S. and Europe, reflecting significant growth potential.

View recap

Burlington Stores, Inc.

BURL Q3 2025

Reported: 2025-11-25

Burlington Stores delivered a solid third quarter with 7% sales growth and significant margin expansion despite weather-related traffic challenges, leading to an optimistic adjustment of full-year earnings guidance.

Key takeaways

Total sales grew by 7% compared to a strong 11% growth in the previous year, aided by a strong back-to-school performance.
Comp store sales increased by 1%, impacted by warmer weather before showing positive momentum in mid-October.
Adjusted full-year EBIT margin guidance upgraded to an expansion of 60 to 70 basis points, reflecting effective expense management and strong margins despite tariff pressures.
Planning for 110 net new store openings in 2026, indicating confidence in new store performance and growth potential.
Long-term operating income target remains on track, projecting growth towards approximately $1.6 billion by 2028.

View recap

Jiayin Group Inc.

JFIN Q3 2025

Reported: 2025-11-25

Jiayin Group Inc. reported robust third-quarter results for 2025, achieving a 20.6% year-on-year increase in loan volume and a 50.3% rise in non-GAAP operating income, supported by a favorable economic landscape and advancements in AI technology.

Key takeaways

Facilitated RMB 32.2 billion in loan volume, marking a 20.6% increase year-over-year.
Non-GAAP income from operations reached RMB 190 million, up 50.3% year-on-year, in line with guidance.
Customer retention strengthened with repeat borrowers contributing 78.6% to facilitation volume; average borrowing amount rose 19.5%.
Implemented advanced AI capabilities for fraud detection, reducing identification time from a week to two hours, enhancing operational efficiency.
Indonesian business saw nearly 200% growth in scale year-on-year, expanding the client base significantly.

View recap

Keysight Technologies, Inc.

KEYS Q4 2025

Reported: 2025-11-25

Keysight Technologies reported a strong fourth quarter for Fiscal Year 2025, with orders up 14%, revenue growth of 10%, and a 16% increase in EPS, all surpassing company guidance.

Key takeaways

Established record free cash flow of $1.3 billion, enabling robust investments in R&D and a new $1.5 billion share repurchase program.
Communication Solutions Group orders grew for the sixth consecutive quarter, bolstered by AI infrastructure and advancements in optical technology.
Continued strong performance in wireless sectors, with high single-digit growth driven by standards evolution and early 6G research collaborations.
Defense and government segment saw record orders, reflecting increased demand for modernization and advanced technology solutions in a competitive global security landscape.
Successful integration of recent acquisitions is enhancing Keysight's capabilities and market offerings, particularly in software-centric solutions.

View recap

LexinFintech Holdings Ltd.

LX Q3 2025

Reported: 2025-11-25

Lexin delivered solid Q3 2025 results, reporting a net profit of RMB 521 million, a 2% increase quarter-over-quarter and a significant 68% growth year-over-year, underscoring resilience in a fluctuating industry landscape.

Key takeaways

Loan volume reached RMB 50.89 billion, with revenue of RMB 3.42 billion, reflecting robust operational performance.
Net profit take rate improved to 2.01%, up 9 basis points quarter-over-quarter and 92 basis points year-over-year.
Increased dividend payout ratio from 25% to 30% of net profit, alongside ongoing share repurchase initiatives.
Successful launch of AI-driven initiatives, with significant enhancements in user request identification accuracy and solution efficiency.
Strong growth across e-commerce segments, particularly in essential daily consumer goods, with GMV increasing by 237% year-over-year during Singles' Day.

View recap

NIO Inc.

NIO Q3 2025

Reported: 2025-11-25

NIO Inc. reported robust third-quarter performance with a 40.8% year-over-year increase in smart EV deliveries, achieving the highest overall gross margin in nearly three years.

Key takeaways

Delivered 87,071 smart EVs in Q3 2025, with monthly deliveries peaking at 40,397 units in October, reflecting a 92.6% year-over-year growth.
Achieved an overall gross margin of 13.9%, bolstered by improved vehicle gross margins at 14.7%.
Non-GAAP operating loss reduced by 30% quarter-over-quarter, marking improved operational efficiency.
Q4 delivery forecast expected between 120,000 and 125,000 units, a significant year-over-year increase of 60.1% to 72%.
Successfully completed $1.16 billion in equity financing, enhancing financial stability for ongoing R&D and infrastructure development.

View recap

Symbotic Inc. Class A Common Stock

SYM Q4 2025

Reported: 2025-11-25

Symbotic delivered strong fourth-quarter results with a 10% revenue increase year-over-year, driven by operational efficiencies and a growing backlog, while net loss was impacted by restructuring expenses and increased stock-based compensation.

Key takeaways

Fourth-quarter revenue reached $618 million, exceeding expectations and reflecting a growing number of systems in operation.
Adjusted EBITDA improved to $49 million, benefiting from higher gross margins and a robust sales pipeline.
Backlog increased to $22.5 billion, bolstered by new projects including a significant contract with Medline in the healthcare vertical.
Operational systems nearly doubled year-over-year, enhancing recurring revenue potential.
Continued focus on micro fulfillment solutions and operational improvements is expected to drive higher future margins.

View recap

Woodward, Inc.

WWD Q4 2025

Reported: 2025-11-25

Woodward, Inc. posted record annual revenues exceeding $3.5 billion for FY 2025, driven by notable growth in both aerospace and industrial segments, yielding all-time high adjusted EPS growth of nearly 13%.

Key takeaways

Aerospace sales surged 14% year-over-year with a margin expansion of 290 basis points, reflecting strong defense OEM performance and increased demand for commercial services.
Industrial revenue growth reached approximately 10%, excluding China, complemented by a core industrial margin improvement of 110 basis points.
Strategic transaction to enhance electromechanical actuation capabilities and expanding Airbus partnerships bolstered future revenue potential.
New facility construction in Spartanburg, SC, and expansion in Gladney are set to enhance production capacity and automation, positioning Woodward well for market demands.
Overall, the company’s focused strategy and operational execution solidified its competitive edge in both aerospace and industrial markets.

View recap

Earnings Recaps

Agilent Technologies, Inc.

Abercrombie & Fitch Co.

Atour Lifestyle Holdings Limited American Depositary Shares

Blue Bird Corporation

BioLineRx Ltd.

Burlington Stores, Inc.

Jiayin Group Inc.

Keysight Technologies, Inc.

LexinFintech Holdings Ltd.

NIO Inc.

Symbotic Inc. Class A Common Stock

Woodward, Inc.

Community

Earnings Recaps

Agilent Technologies, Inc.

Abercrombie & Fitch Co.

Atour Lifestyle Holdings Limited American Depositary Shares

Blue Bird Corporation

BioLineRx Ltd.

Burlington Stores, Inc.

Jiayin Group Inc.

Keysight Technologies, Inc.

LexinFintech Holdings Ltd.

NIO Inc.

Symbotic Inc. Class A Common Stock

Woodward, Inc.

Community

Trending This Week

Notifications